Meihua International Medical Technologies Co., Ltd. (MHUA) Financials
Newest figures come from the 10-K for FY2025, filed Apr 29, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MHUA SEC filings page.
Meihua International Medical Technologies Co., Ltd. (MHUA) reported $61.8M in revenue for fiscal year 2025, down 36.2% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue contracted sharply in FY2025, while low leverage and weak cash conversion show a business financed more by equity than operations.
FY2025 net income of$6.8M sat far above operating cash flow of$0.6M , so reported profit did not translate cleanly into cash. That mismatch coincided with receivables rising7.2% while revenue fell36.2% , pointing to working capital absorbing cash rather than a simple profitability issue.
The top-line contraction was paired with gross-margin compression from
Assets expanded to
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Meihua International Medical Technologies Co., Ltd.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Meihua International Medical Technologies Co., Ltd. has an operating margin of 13.4%, meaning the company retains $13 of operating profit per $100 of revenue. This strong profitability earns a score of 74/100, reflecting efficient cost management and pricing power. This is down from 14.8% the prior year.
Meihua International Medical Technologies Co., Ltd.'s revenue declined 36.2% year-over-year, from $96.9M to $61.8M. This contraction results in a growth score of 4/100.
Meihua International Medical Technologies Co., Ltd. carries a low D/E ratio of 0.10, meaning only $0.10 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 81/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 8.41, Meihua International Medical Technologies Co., Ltd. holds $8.41 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 97/100.
Meihua International Medical Technologies Co., Ltd. has a free cash flow margin of 0.9%, earning a moderate score of 45/100. The company generates positive cash flow after capital investments, but with room for improvement.
Meihua International Medical Technologies Co., Ltd.'s ROE of 3.6% shows moderate profitability relative to equity, earning a score of 53/100. This is down from 6.8% the prior year.
Meihua International Medical Technologies Co., Ltd. passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Meihua International Medical Technologies Co., Ltd. generates $0.08 in operating cash flow ($570K OCF vs $6.8M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Meihua International Medical Technologies Co., Ltd. earns $34.30 in operating income for every $1 of interest expense ($8.3M vs $242K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
None of these metrics is reported for Q4 2025.
Cash & Balance Sheet
Meihua International Medical Technologies Co., Ltd. held $15.2M in cash as of Q4 2025; long-term debt is not reported for that period.
Not reported for Q4 2025.
Not reported for Q4 2025.
Margins & Returns
None of these metrics is reported for Q4 2025.
Capital Allocation
None of these metrics is reported for Q4 2025.
MHUA Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
MHUA Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2510-K | Q2'256-K | Q4'2410-K | Q2'24 | Q4'23 | Q2'23 | Q4'22 | Q4'21 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $207.2M+11.2% | $190.6M+6.4% | $186.2M+8.3% | $179.2M+10.2% | $171.9M+5.1% | $162.6M | $163.6M+19.5% | $136.9M+29.1% |
| Current Assets | $153.6M+7.1% | $146.3M+3.6% | $143.4M+8.5% | $141.3M+6.8% | $132.2M-2.3% | $132.3M | $135.3M+39.1% | $97.3M+44.0% |
| Cash & Equivalents | $15.2M-12.3% | $16.9M-8.6% | $17.3M+2.1% | $18.5M+3.5% | $16.9M-36.7% | $17.9M | $26.7M+228.1% | $8.1M+13.4% |
| Inventory | $1.7M+20.9% | $1.1M+0.8% | $1.4M-12.8% | $1.1M-33.7% | $1.6M+44.1% | $1.6M | $1.1M-10.3% | $1.3M-5.6% |
| Accounts Receivable | $84.3M+7.2% | $86.6M+4.9% | $78.7M+0.1% | $82.6M+4.4% | $78.6M+14.0% | $79.1M | $68.9M+2.7% | $67.1M+46.8% |
| Goodwill | N/A | N/A | $7.9M | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $18.3M-33.1% | $25.6M-13.4% | $27.3M+8.7% | $29.6M+27.4% | $25.1M+0.7% | $23.2M | $24.9M-14.4% | $29.1M+36.5% |
| Current Liabilities | $18.3M-33.1% | $25.6M-13.4% | $27.3M+8.7% | $29.6M+27.4% | $25.1M+3.7% | $23.2M | $24.2M-16.9% | $29.1M+36.5% |
| Non-Current Liabilities | $0 | $0 | $0-100.0% | $0 | $5K-99.4% | $0 | $725K | $0 |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | $725K | N/A |
| Total Equity | $188.9M+18.8% | $164.9M+10.3% | $159.0M+8.6% | $149.6M+7.7% | $146.3M+5.9% | $138.9M | $138.1M+28.2% | $107.8M+27.2% |
| Retained Earnings | $111.9M+6.4% | $108.3M+9.1% | $105.2M+11.2% | $99.3M+9.8% | $94.6M+13.6% | $90.4M | $83.3M+7.4% | $77.6M+37.0% |
Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments.
MHUA Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.
MHUA Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Meihua International Medical Technologies Co., Ltd. MHUA | FY2025 | $61.8M | $6.8M | 11.0% | N/A | 59/100 |
| Femasys Inc. FEMY | FY2025 | $2.3M | -$18.6M | N/A | $16.8M | 43/100 |
| Harvard Bioscience Inc HBIO | FY2025 | $86.5M | -$56.7M | -65.5% | $37.5M | 38/100 |
| Ekso Bionics Holdings, Inc. EKSO | FY2025 | $12.8M | -$11.7M | -91.4% | $42.0M | 36/100 |
| Innovative Eyewear, Inc. LUCY | FY2025 | $2.7M | -$7.6M | N/A | $7.9M | 59/100 |
| Retractable Technologies, Inc RVP | FY2025 | $38.3M | -$12.6M | -32.8% | $19.8M | 24/100 |
Where Meihua International Medical Technologies Co., Ltd. Ranks
Frequently Asked Questions
What is Meihua International Medical Technologies Co., Ltd.'s annual revenue?
Meihua International Medical Technologies Co., Ltd. (MHUA) reported $61.8M in total revenue for fiscal year 2025. This represents a -36.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Meihua International Medical Technologies Co., Ltd.'s revenue growing?
Meihua International Medical Technologies Co., Ltd. (MHUA) revenue declined by 36.2% year-over-year, from $96.9M to $61.8M in fiscal year 2025.
Is Meihua International Medical Technologies Co., Ltd. profitable?
Yes, Meihua International Medical Technologies Co., Ltd. (MHUA) reported a net income of $6.8M in fiscal year 2025, with a net profit margin of 11.0%.
What is Meihua International Medical Technologies Co., Ltd.'s EBITDA?
Meihua International Medical Technologies Co., Ltd. (MHUA) had EBITDA of $8.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Meihua International Medical Technologies Co., Ltd.'s gross margin?
Meihua International Medical Technologies Co., Ltd. (MHUA) had a gross margin of 31.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Meihua International Medical Technologies Co., Ltd.'s operating margin?
Meihua International Medical Technologies Co., Ltd. (MHUA) had an operating margin of 13.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Meihua International Medical Technologies Co., Ltd.'s net profit margin?
Meihua International Medical Technologies Co., Ltd. (MHUA) had a net profit margin of 11.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Meihua International Medical Technologies Co., Ltd.'s return on equity (ROE)?
Meihua International Medical Technologies Co., Ltd. (MHUA) has a return on equity of 3.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Meihua International Medical Technologies Co., Ltd.'s free cash flow?
Meihua International Medical Technologies Co., Ltd. (MHUA) generated $554K in free cash flow during fiscal year 2025. This represents a -96.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Meihua International Medical Technologies Co., Ltd.'s operating cash flow?
Meihua International Medical Technologies Co., Ltd. (MHUA) generated $570K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Meihua International Medical Technologies Co., Ltd.'s total assets?
Meihua International Medical Technologies Co., Ltd. (MHUA) had $207.2M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Meihua International Medical Technologies Co., Ltd.'s capital expenditures?
Meihua International Medical Technologies Co., Ltd. (MHUA) invested $16K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Meihua International Medical Technologies Co., Ltd. spend on research and development?
Meihua International Medical Technologies Co., Ltd. (MHUA) invested $2.4M in research and development during fiscal year 2025.
What is Meihua International Medical Technologies Co., Ltd.'s current ratio?
Meihua International Medical Technologies Co., Ltd. (MHUA) had a current ratio of 8.41 as of fiscal year 2025, which is generally considered healthy.
What is Meihua International Medical Technologies Co., Ltd.'s debt-to-equity ratio?
Meihua International Medical Technologies Co., Ltd. (MHUA) had a debt-to-equity ratio of 0.10 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Meihua International Medical Technologies Co., Ltd.'s return on assets (ROA)?
Meihua International Medical Technologies Co., Ltd. (MHUA) had a return on assets of 3.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Meihua International Medical Technologies Co., Ltd.'s Piotroski F-Score?
Meihua International Medical Technologies Co., Ltd. (MHUA) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Meihua International Medical Technologies Co., Ltd.'s earnings high quality?
Meihua International Medical Technologies Co., Ltd. (MHUA) has an earnings quality ratio of 0.08x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Meihua International Medical Technologies Co., Ltd. cover its interest payments?
Meihua International Medical Technologies Co., Ltd. (MHUA) has an interest coverage ratio of 34.30x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Meihua International Medical Technologies Co., Ltd.?
Meihua International Medical Technologies Co., Ltd. (MHUA) scores 59 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.